BioWorld

June 15, 1995

View Archived Issues

SEQUANA FILES FOR IPO, SIGNS POTENTIAL $70M ASTHMA DEAL

Read More

POOR INTEGRELIN SHOWING HALTS BRIEF SURGE IN BIOTECH STOCKS

Read More

COST, EFFECTS OF ADVERSE EVENT REPORTING REGULATIONS DETAILED BY

Read More

SWISS GOVERNMENT URGES YES VOTE ON GENETIC ENGINEERING

Read More